BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bandyopadhyay GK, Mahata SK. Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity. Front Endocrinol (Lausanne). 2017;8:20. [PMID: 28228748 DOI: 10.3389/fendo.2017.00020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Guest PC. Biogenesis of the Insulin Secretory Granule in Health and Disease. Adv Exp Med Biol 2019;1134:17-32. [PMID: 30919330 DOI: 10.1007/978-3-030-12668-1_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Simunovic M, Supe-Domic D, Karin Z, Degoricija M, Paradzik M, Bozic J, Unic I, Skrabic V. Serum catestatin concentrations are decreased in obese children and adolescents. Pediatr Diabetes. 2019;20:549-555. [PMID: 30714297 DOI: 10.1111/pedi.12825] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Li M, Du W, Zhou M, Zheng L, Song E, Hou J. Proteomic analysis of insulin secretory granules in INS-1 cells by protein correlation profiling. Biophys Rep 2018;4:329-38. [PMID: 30596141 DOI: 10.1007/s41048-018-0061-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Castañeyra-Ruiz L, Castañeyra A, González-Santana A, Machado JD, Borges R. Combining the lack of chromogranins with chronic L-DOPA treatment affects motor activity in mice. Cell Tissue Res 2020;380:59-66. [PMID: 31900665 DOI: 10.1007/s00441-019-03159-8] [Reference Citation Analysis]
5 Corti A, Marcucci F, Bachetti T. Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers. Pflugers Arch 2018;470:199-210. [PMID: 29018988 DOI: 10.1007/s00424-017-2030-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
6 Mahata SK, Corti A. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation. Ann N Y Acad Sci. 2019;1455:34-58. [PMID: 31588572 DOI: 10.1111/nyas.14249] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
7 Bourebaba Y, Mularczyk M, Marycz K, Bourebaba L. Catestatin peptide of chromogranin A as a potential new target for several risk factors management in the course of metabolic syndrome. Biomed Pharmacother 2021;134:111113. [PMID: 33341043 DOI: 10.1016/j.biopha.2020.111113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Herold Z, Doleschall M, Somogyi A. Role and function of granin proteins in diabetes mellitus. World J Diabetes 2021;12:1081-92. [PMID: 34326956 DOI: 10.4239/wjd.v12.i7.1081] [Reference Citation Analysis]
9 Muntjewerff EM, Dunkel G, Nicolasen MJT, Mahata SK, van den Bogaart G. Catestatin as a Target for Treatment of Inflammatory Diseases. Front Immunol 2018;9:2199. [PMID: 30337922 DOI: 10.3389/fimmu.2018.02199] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
10 Borovac JA, Glavas D, Susilovic Grabovac Z, Supe Domic D, D'Amario D, Bozic J. Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study. J Clin Med. 2019;8. [PMID: 31366074 DOI: 10.3390/jcm8081132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
11 Bandyopadhyay G, Tang K, Webster NJG, van den Bogaart G, Mahata SK. Catestatin induces glycogenesis by stimulating the phosphoinositide 3-kinase-AKT pathway. Acta Physiol (Oxf) 2022;235:e13775. [PMID: 34985191 DOI: 10.1111/apha.13775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Borovac JA, Dogas Z, Supe-Domic D, Galic T, Bozic J. Catestatin serum levels are increased in male patients with obstructive sleep apnea. Sleep Breath 2019;23:473-81. [PMID: 30088239 DOI: 10.1007/s11325-018-1703-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Muntjewerff EM, Tang K, Lutter L, Christoffersson G, Nicolasen MJT, Gao H, Katkar GD, Das S, Ter Beest M, Ying W, Ghosh P, El Aidy S, Oldenburg B, van den Bogaart G, Mahata SK. Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides. Acta Physiol (Oxf) 2021;232:e13655. [PMID: 33783968 DOI: 10.1111/apha.13655] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
14 Watanabe T. The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease. Int J Mol Sci 2021;22:6118. [PMID: 34204153 DOI: 10.3390/ijms22116118] [Reference Citation Analysis]
15 Carmon O, Laguerre F, Riachy L, Delestre-Delacour C, Wang Q, Tanguy E, Jeandel L, Cartier D, Thahouly T, Haeberlé AM, Fouillen L, Rezazgui O, Schapman D, Haefelé A, Goumon Y, Galas L, Renard PY, Alexandre S, Vitale N, Anouar Y, Montero-Hadjadje M. Chromogranin A preferential interaction with Golgi phosphatidic acid induces membrane deformation and contributes to secretory granule biogenesis. FASEB J 2020;34:6769-90. [PMID: 32227388 DOI: 10.1096/fj.202000074R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Abd-Elhafeez HH, Abou-Elhamd AS, Soliman SA. Morphological and immunohistochemical phenotype of TCs in the intestinal bulb of Grass carp and their potential role in intestinal immunity. Sci Rep 2020;10:14039. [PMID: 32820212 DOI: 10.1038/s41598-020-70032-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Alam MJ, Gupta R, Mahapatra NR, Goswami SK. Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling. Mol Cell Biochem. 2020;464:205-219. [PMID: 31792650 DOI: 10.1007/s11010-019-03661-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
18 Thomsen SK, Raimondo A, Hastoy B, Sengupta S, Dai XQ, Bautista A, Censin J, Payne AJ, Umapathysivam MM, Spigelman AF, Barrett A, Groves CJ, Beer NL, Manning Fox JE, McCarthy MI, Clark A, Mahajan A, Rorsman P, MacDonald PE, Gloyn AL. Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells. Nat Genet 2018;50:1122-31. [PMID: 30054598 DOI: 10.1038/s41588-018-0173-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
19 Bozic J, Kumric M, Ticinovic Kurir T, Urlic H, Martinovic D, Vilovic M, Tomasovic Mrcela N, Borovac JA. Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective. Biomedicines 2021;9:1757. [PMID: 34944578 DOI: 10.3390/biomedicines9121757] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]